Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,729 evidence items · page 20 / 70

34 casesRefractive error was the most common cause of mild visual impairment in 34 (29.6%) cases.

Nigeriarefractive error · VIH/sidapublished 2023West African journal of medicinePubMeddocument of 9 observations

10.9 %The prevalence of HIV infection among voluntary blood donors at Nkenkaasu District Hospital's Blood Bank from January 2010 to December 2018 was 10.9%.

NigeriaVIH/sidaobserved January 2010 to December 2018published 2022African health sciencesPubMeddocument of 2 observations

18 %Every quartile-unit increase in the syndemic index was associated with an 18% increase in prevalence of HIV among sexual and gender minority people in Abuja, Nigeria.

NigeriaVIH/sidapublished 2026AIDS and behaviorPubMeddocument of 2 observations

Participants identified patients with HIV within the age range of 18–40 as the most suitable population to benefit from using Smart Lockers for medication dispensing.

NigeriaVIH/sidapublished 2024PloS onePubMeddocument of 10 observations

81 %In 2020, 81% of surveyed key population participants in Nigeria were willing to pay for HIV self-testing (HIVST) kits.

NigeriaVIH/sidaobserved 2020published 2022Global health, science and practicePubMeddocument of 3 observations

4,471 individualsThe study recruited a convenience sample of 4471 adults in Nigeria, of whom 20.5% were HIV positive.

NigeriaVIH/sidapublished 2022AIDS and behaviorPubMeddocument of 4 observations

3 yearsThe mean age of HIV-infected children was 3.0 ± 0.9 years.

NigeriaVIH/sidapublished 2020West African journal of medicinePubMeddocument of 8 observations

4.932 AORTraders had an adjusted odds ratio of 4.932 for TB/HIV coinfection.

Nigeriatuberculose · VIH/sidaobserved 2018-2022published 2024BMJ openPubMeddocument of 6 observations

11.5 %Among 43788 clients initiating daily oral PrEP in Nigeria between January 2020 and March 2023, the 6-month continuation rate was 11.5%.

NigeriaVIH/sidaobserved January 2020 to March 2023published 2025BMJ global healthPubMeddocument of 7 observations

12 %About 12% of in-school youths were engaged in at least one HIV/AIDS risk behaviour.

NigeriaVIH/sidapublished 2025BMC public healthPubMeddocument of 3 observations

100 %Minor PI resistance-associated mutation K20I was identified in 100% of CRF02_AG HIV-1 isolates.

NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 11 observations

1.2 %Among 57,687 participants who self-reported being HIV-negative in NAIIS, 686 (1.2%) tested HIV-positive via rapid diagnostic test.

NigeriaVIH/sidapublished 2022PloS onePubMeddocument of 8 observations

245,257 patientsWithin the review period from 2004 to 2017, 245,257 patients were ever enrolled on antiretroviral therapy in a large HIV program across 432 PEPFAR-supported facilities in 10 States and FCT in Nigeria.

NigeriaVIH/sidaobserved 2004 to 2017published 2019AIDS research and therapyPubMeddocument of 11 observations

22,010 inhabitantsOf the 22,010 study subjects receiving HIV treatment in private facilities in the Federal Capital Territory, Benue, and Nasarawa states in north-central Nigeria, 42.7% were in Benue, 22.2% in the Federal Capital Territory, and 35.1% in Nasarawa.

NigeriaVIH/sidaobserved 2013–2019published 2022AIDS research and therapyPubMeddocument of 3 observations

102,165 individualsThe number of HIV-positive individuals identified increased from 21,234 to 102,165 between the pre-surge and post-surge periods in Akwa Ibom State, Nigeria.

NigeriaVIH/sidapublished 2022PloS onePubMeddocument of 7 observations

38.4 %Among individuals initiated on antiretroviral therapy within 14 days of HIV diagnosis, 38.4% were lost to follow-up by 12 months in Nigeria.

NigeriaVIH/sidapublished 2023PloS onePubMeddocument of 3 observations

39.7 %Stigma reduced access to antiretroviral therapy for 39.7% of respondents.

NigeriaVIH/sidapublished 2026Scientific reportsPubMeddocument of 6 observations

58 %Among 307 men who have sex with men (MSM) surveyed, 58% were living with HIV.

NigeriaVIH/sidaobserved 2017published 2020BMC cancerPubMeddocument of 8 observations

10 %Malaria RDT result was positive in 6/60 (10%) of the ARV-naïve HIV-infected group.

Nigeriapaludisme · VIH/sidaobserved 2018–2019published 2024BMC infectious diseasesPubMeddocument of 15 observations

6 %6% of patients were sero-positive for HIV infection.

NigeriaVIH/sidapublished 2011Acta tropicaeurope_pmcdocument of 5 observations

33 percentage_pointsThere was a 33% excess probability of urban women testing for HIV during antenatal care compared with rural women.

NigeriaVIH/sidaobserved 2013published 2020Journal of biosocial sciencePubMeddocument of 4 observations

12.2 %The prevalence of Epstein-Barr virus (EBV) infection among HIV patients in Nigeria was 12.2%.

NigeriaEpstein-Barr virus (EBV) infection · VIH/sidapublished 2022Indian journal of medical microbiologyPubMeddocument of 8 observations

9.5 %The overall missed opportunity for antiretroviral therapy initiation among antenatal care attendees in Nigeria was 9.5% in 2019.

NigeriaVIH/sidaobserved 2019published 2023AIDS carePubMeddocument of 7 observations

0.932 AORStigma was negatively associated with adequate social support overall (Adjusted Odds Ratio: 0.932; 95% Confidence Interval: 0.883–0.983).

NigeriaVIH/sidapublished 2023Frontiers in public healthPubMeddocument of 9 observations

48 %48% of the study participants were HIV negative.

NigeriaVIH/sidapublished 2020BMC medical geneticsPubMeddocument of 6 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.